Lauder is responding to shifting trends with greater agility than ever while leveraging enhanced data analytics and consumer insight to innovate ahead of the curve, leadership says. Following 11% constant-currency growth in the fiscal 2020 first quarter, the firm is forecasting 8% to 9% net sales gains for the full year.
Confidence in its diversified growth platform has the [Estee Lauder Companies Inc.] forecasting 8% to 9% constant-currency sales growth in fiscal 2020, even as it braces for deceleration in China and travel retail in what remains a highly volatile global environment.
Previously, the firm targeted 7% to 8% growth in full-year 2020 revenues, but that was before booking sales of $3.9bn...
The gut’s microbiome will shape future medical advances, offering personalized therapies and prevention strategies for a wide range of diseases.
A look at new research on the cardiovascular effects of ADHD medications and what it means for clinical care. This article explores the latest clinical and epidemiological research on the cardiovascular effects of medications commonly prescribed for ADHD, examining potential heart-related risks, underlying mechanisms, and their implications for patient safety, clinical decision-making, and long-term treatment strategies across diverse age groups and risk profiles.
CEO Sue Nabi says Coty has created a “multi-functional, stand-alone organization” within its Consumer Beauty business to drive rapid-fire innovation. In a 20 August presentation, Nabi said the firm’s innovation pipeline undergirds its fiscal 2025 outlook of 6%-8% growth.
The gut’s microbiome will shape future medical advances, offering personalized therapies and prevention strategies for a wide range of diseases.
A look at new research on the cardiovascular effects of ADHD medications and what it means for clinical care. This article explores the latest clinical and epidemiological research on the cardiovascular effects of medications commonly prescribed for ADHD, examining potential heart-related risks, underlying mechanisms, and their implications for patient safety, clinical decision-making, and long-term treatment strategies across diverse age groups and risk profiles.
